| Vol. 17.11 – 22 March, 2023 |
| |
|
|
| To further investigate the epigenetic mechanisms underlying gene expression regulation, scientists developed spatially resolved, genome-wide comapping of the epigenome and transcriptome by simultaneous profiling of chromatin accessibility and messenger RNA expression. [Nature] |
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers described a method for prospectively isolating ten distinct neural stem and progenitor cell types from the developing human brain using cell-surface markers. [Cell] |
|
|
|
| Scientists determined that TDP-43 binding in the first intron of the STMN2 pre-mRNA sterically blocked access of RNA processing factors that would otherwise recognize and use a cryptic 3′ splice site. [Science] |
|
|
|
| Investigators characterized an alternative 3′ splice site (A3SS) of SYNGAP1 that induced nonsense-mediated mRNA decay in mouse and human neural development. They demonstrated that PTBP1/2 directly bound to and promoted SYNGAP1 A3SS inclusion. [Neuron] |
|
|
|
| Researchers found that loss of the membrane:cytoskeleton-associated neurofibromatosis type 2 (NF2) tumor suppressor, merlin, yielded unstable intrinsic polarity and enabled Nf2-/- Schwann cells to adopt distinct programs of ErbB ligand production and polarized signaling. [Nature Communications] |
|
|
|
| Using global metabolomic profiling of patient-derived brain tumors, investigators identified the downstream metabolism of tryptophan and accumulation of quinolinate as a metabolic node in glioblastoma and demonstrate its critical role in promoting immune tolerance. [Nature Communications] |
|
|
|
| Using neuronal cells expressing the wild type form of amyloid precursor protein infected by herpes simplex virus type-1 (HSV-1), scientists characterized a representative cellular model of the early stage of the sporadic form of the disease and unraveled a mechanism sustaining this HSV-1- Alzheimer’s interplay. [Translational Psychiatry] |
|
|
|
| Researchers evaluated a cell therapy treatment using mouse-induced pluripotent stem cell-derived (iPSC) neural precursor cells engineered to overexpress lysosomal acid β-glucosidase. [Molecular Therapy-Methods & Clinical Development] |
|
|
|
| Investigators reported that ginsenoside Rg1 effectively suppressed the inflammatory activation of brain microglia cells under cerebral ischemia/reperfusion conditions depending on the inhibition of Toll-like receptor4 proteins. [Experimental Cell Research] |
|
|
|
|
| The authors review the current knowledge of general and central nervous system-specific mechanisms of angiogenesis during brain development and in brain vascular malformations and brain tumors, including how key molecular signaling pathways are reactivated in vascular-dependent diseases. [Nature Reviews Neuroscience] |
|
|
|
| Scientists briefly describe the current understanding of how pathological tau exerts dual effects on neuronal death by acting as a double-edged sword in different neurological diseases. [Molecular Psychiatry] |
|
|
|
|
| Novartis announced the US FDA granted approval for Tafinlar® + Mekinist® for the treatment of pediatric patients 1 year of age and older with low-grade glioma with a BRAF V600E mutation who require systemic therapy. [Novartis] |
|
|
|
|
| April 14 – 19, 2023 Orlando, Florida, United States |
|
|
|
|
|
| University of Amsterdam – Amsterdam, Netherlands |
|
|
|
| Columbia University – New York City, New York, United States |
|
|
|
| Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
| University of Pennsylvania – Philadelphia, Pennsylvania, United States |
|
|
|
| Swiss Federal Institute of Technology Lausanne – Lausanne, Switzerland |
|
|
|
|